FIVN Insider Notice: 4,212 RSUs to be Sold via Morgan Stanley
Rhea-AI Filing Summary
Form 144 Notice for Five9, Inc. (FIVN) reports a proposed sale of 4,212 common shares acquired as restricted stock units on 09/03/2025. The filing lists Morgan Stanley Smith Barney LLC as the broker and an aggregate market value of $111,533.76 for the proposed sale, with an approximate sale date of 09/04/2025 on NASDAQ. The filing also discloses three prior 10b5-1 sales by Andrew Dignan during the past three months: 700 shares on 08/01/2025 for $18,312.00, 700 shares on 07/01/2025 for $18,508.00, and 700 shares on 06/05/2025 for $20,461.00. The filer affirms they are unaware of undisclosed material adverse information.
Positive
- Clear disclosure of a proposed insider sale specifying shares, acquisition date, and broker
- Prior 10b5-1 sales are itemized, providing transparency about recent insider transactions
Negative
- None.
Insights
TL;DR: Routine insider sale notice showing a planned disposition of newly vested RSUs and recent 10b5-1 sales; no financial results disclosed.
The Form 144 documents a proposed sale of 4,212 common shares tied to restricted stock units acquired on 09/03/2025, with Morgan Stanley Smith Barney LLC noted as broker and an aggregate market value of $111,533.76. Prior 10b5-1 sales by Andrew Dignan total 2,100 shares across June–August 2025, generating gross proceeds reported per transaction. As a securities filing, this provides transparency on insider liquidity but contains no operational or earnings information to affect company valuation directly.
TL;DR: Filing is a standard Rule 144 disclosure; it documents compliance with reporting requirements and includes 10b5-1 sales history.
The notice identifies the nature and timing of the securities (RSUs acquired and proposed sale the next day) and lists prior 10b5-1 executions by the same individual. The signature/attestation language affirms absence of undisclosed material adverse information as of the plan/instruction date. The form meets procedural disclosure expectations but does not provide the plan adoption date or additional contextual details beyond transaction facts.